רשימת מקורות למאמר: הסכנה המסתתרת בשייק שלך

כתבה: Sally K. Norton

1. Crampton RF, Charlesworth FA. Occurrence of natural toxins in food. Br
Med Bull 1975;31(3):209–213.
2. Moffatt RE. Renal oxalosis in the cat. Can Vet J Rev Vét Can
1977;18(12):351.
3. Waltner-Toews D, Meadows DH. Urolithiasis in a Herd of Beef Cattle
Associated with Oxalate Ingestion. Can Vet J 1980;21(2):61–62.
4. Clendinning J. Observations on the History of Oxalic Acid as a Poison. Lond
Med Surg J 1833;III:586–588.
5. Blyth AW. Poisons: their effects and detection: a manual for the use of
analytical chemists and experts; with an introductory essay on the growth of
modern toxicology. London: C. Griffin; 1884.
6. Christison R, Coindet C. An experimental inquiry on poisoning by oxalic
acid. Edinb Med Surg J Exhib Concise View Latest Most Important Discov
Med Surg Pharm 1823;
7. Lorenz EC, Michet CJ, Milliner DS, Lieske JC. Update on Oxalate Crystal
Disease. Curr Rheumatol Rep 2013;15(7):340.
8. Getting JE, Gregoire JR, Phul A, Kasten MJ. Oxalate Nephropathy Due to
‘Juicing’: Case Report and Review. Am J Med 2013;126(9):768–772.
9. Tallqvist H, Vaananen I. Death of a child from oxalic acid poisoning due to
eating rhubarb leaves. Ann Paediatr Fenn 1960;6:144–7.
10. Kalliala H, Kauste O. Ingestion of rhubarb leaves as cause of oxalic acid
poisoning. Ann Paediatr Fenn 1964;10:228–231.
11. Robb H. Death from rhubarb leaves due to oxalic acid poisoning. J Am Med
Assoc 1919;73(8):627–628.
12. Sanz P, Reig R. Clinical and pathological findings in fatal plant oxalosis. A
review. Am J Forensic Med Pathol 1992;13(4):342–345.
13. Chen CL, Fang HC, Chou KJ, Wang JS, Chung HM. Acute oxalate
nephropathy after ingestion of star fruit. Am J Kidney Dis Off J Natl Kidney
Found 2001;37(2):418–422

Neto MM, Costa JAC da, Garcia‐Cairasco N, Netto JC, Nakagawa B, Dantas
M. Intoxication by star fruit (Averrhoa carambola) in 32 uraemic patients:
treatment and outcome. Nephrol Dial Transplant 2003;18(1):120–125.
15. Chang JM, Hwang SJ, Kuo HT, et al. Fatal outcome after ingestion of star
fruit (Averrhoa carambola) in uremic patients. Am J Kidney Dis Off J Natl
Kidney Found 2000;35(2):189–193.
16. Farre M, Xirgu J, Salgado A, Peracaula R, Reig R, Sanz P. Fatal oxalic acid
poisoning from sorrel soup. The Lancet 1989;334(8678–8679):1524.
17. Marengo SR, Romani AMP. Oxalate in renal stone disease: the terminal
metabolite that just won’t go away. Nat Clin Pract Nephrol 2008;4(7):368–
377.
18. Prychid CJ, Jabaily RS, Rudall PJ. Cellular Ultrastructure and Crystal
Development in Amorphophallus (Araceae). Ann Bot 2008;101(7):983–995.
19. Crowther A. Re-viewing raphides: Issues with the identification and
interpretation of calcium oxalate crystals in microfossil assemblages
[Internet]. In: Fairbairn AS, O’Connor S, Marwick B, editors. New
Directions In Archaeological Science. Terra Austrailis 28, ANU E-Press;
2009 [cited 2015 Jul 31]. p. 105–118.Available from:
http://www.academia.edu/2561859/Reviewing_raphides_Issues_with_the_identification_and_interpretation_of_cal
cium_oxalate_crystals_in_microfossil_assemblages
20. Salinas ML, Ogura T, Soffchi L. Irritant contact dermatitis caused by needlelike calcium oxalate crystals, raphides, in Agave tequilana among workers in
tequila distilleries and agave plantations. Contact Dermatitis 2001;44(2):94–
96.
21. Altin G, Sanli A, Erdogan BA, Paksoy M, Aydin S, Altintoprak N. Severe
destruction of the upper respiratory structures after brief exposure to a
dieffenbachia plant. J Craniofac Surg 2013;24(3):e245-247.
22. Konno K, Inoue TA, Nakamura M. Synergistic defensive function of
raphides and protease through the needle effect. PloS One 2014;9(3):e91341.
23. Ilarslan H, Palmer RG, Horner HT. Calcium Oxalate Crystals in Developing
Seeds of Soybean. Ann Bot 2001;88(2):243–257.

24. Lersten NR, Horner HT. Development of the calcium oxalate crystal
macropattern in pomegranate (Punica granatum, Punicaceae). Vol 92
2005;92(12):1935–1941.
25. Webb MA. Cell-mediated crystallization of calcium oxalate in plants. Plant
Cell 1999;11(4):751–761.
26. Franceschi V. Calcium oxalate in plants. Trends Plant Sci 2001;6(7):331.
27. Danielson DR, Reinhard KJ. Human dental microwear caused by calcium
oxalate phytoliths in prehistoric diet of the lower Pecos region, Texas. Am J
Phys Anthropol 1998;107(3):297–304.
28. McIntire MS, Guest JR, Porterfield JF. Philodendron–an infant death. J
Toxicol Clin Toxicol 1990;28(2):177–183.
29. Heaney RP, Weaver CM. Oxalate: effect on calcium absorbability. Am J
Clin Nutr 1989;50(4):830–832.
30. Israr B, Frazier RA, Gordon MH. Effects of phytate and minerals on the
bioavailability of oxalate from food. Food Chem 2013;141(3):1690–1693.
31. Massey LK. Food oxalate: factors affecting measurement, biological
variation, and bioavailability. J Am Diet Assoc 2007;107(7):1191-1194; quiz
1195-1196.
32. Marengo S, Zeise B, Wilson C, MacLennan G, Romani AP. The triggermaintenance model of persistent mild to moderate hyperoxaluria induces
oxalate accumulation in non-renal tissues. Urolithiasis 2013;41(6):455–466.
33. Blumenfrucht MJ, Cheeks C, Wedeen RP. Multiorgan crystal deposition
following intravenous oxalate infusion in rat. J Urol 1986;135(6):1274–
1279.
34. Holmes RP, Ambrosius WT, Assimos DG. Dietary oxalate loads and renal
oxalate handling. J Urol 2005;174(3):943–947; discussion 947.
35. Wang Z, Tangella K, Balla A, Popescu G. Tissue refractive index as marker
of disease. J Biomed Opt [Internet] 2011 [cited 2015 Jun 16];16(11).
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223513/

36. Radi MJ. Calcium oxalate crystals in breast biopsies. An overlooked form of
microcalcification associated with benign breast disease. Arch Pathol Lab
Med 1989;113(12):1367–1369.
37. Katoh R, Suzuki K, Hemmi A, Kawaoi A. Nature and significance of
calcium oxalate crystals in normal human thyroid gland. A
clinicopathological and immunohistochemical study. Virchows Arch A
Pathol Anat Histopathol 1993;422(4):301–306.
38. Glew RH, Sun Y, Horowitz BL, et al. Nephropathy in dietary hyperoxaluria:
A potentially preventable acute or chronic kidney disease. World J Nephrol
2014;3(4):122–142.
39. Siener R, Hönow R, Voss S, Seidler A, Hesse A. Oxalate content of cereals
and cereal products. J Agric Food Chem 2006;54(8):3008–3011.
40. Chai W, Liebman M. Oxalate content of legumes, nuts, and grain-based
flours. J Food Compos Anal 2005;18(7):723–729.
41. Salyer WR, Hutchins GM. Cardiac lesions in secondary oxalosis. Arch
Intern Med 1974;134(2):250–252.
42. Fishbein GA, Micheletti RG, Currier JS, Singer E, Fishbein MC.
Atherosclerotic Oxalosis in Coronary Arteries. Cardiovasc Pathol Off J Soc
Cardiovasc Pathol 2008;17(2):117–123.
43. Shavit L, Girfoglio D, Vijay V, et al. Vascular calcification and bone
mineral density in recurrent kidney stone formers. Clin J Am Soc Nephrol
CJASN 2015;10(2):278–285.
44. Aydin NE, Usta U. Oxalate deposition in tissues. Nephrol Dial Transplant
2004;19(5):1323–1324.
45. Maldonado I, Prasad V, Reginato AJ. Oxalate crystal deposition disease.
Curr Rheumatol Rep 2002;4(3):257–264.
46. Brancaccio D, Poggi A, Ciccarelli C, et al. Bone changes in end-stage
oxalosis. AJR Am J Roentgenol 1981;136(5):935–939.
47. Fielder AR, Garner A, Chambers TL. Ophthalmic manifestations of primary
oxalosis. Br J Ophthalmol 1980;64(10):782–788.

48. Boogaerts MA, Hammerschmidt DE, Roelant C, Verwilghen RL, Jacob HS.
Mechanisms of vascular damage in gout and oxalosis: crystal induced,
granulocyte mediated, endothelial injury. Thromb Haemost 1983;50(2):576–
580.
49. Johnson J, Short A, Hutchison A, Parrott N, Roberts I. Small intestinal
infarction: a fatal complication of systemic oxalosis. J Clin Pathol
2000;53(9):720–721.
50. Bimstein E, Wagner M, Nauman RK, Abrams RG, Shapira L. Root surface
characteristics of primary teeth from children with prepubertal periodontitis.
J Periodontol 1998;69(3):337–347.
51. Panis V, Tosios KI, Gagari E, Griffin TJ, Damoulis PD. Severe periodontitis
in a patient with hyperoxaluria and oxalosis: a case report and review of the
literature. J Periodontol 2010;81(10):1497–1504.
52. Lapointe HJ, Listrom R. Oral manifestations of oxalosis secondary to
ileojejunal intestinal bypass. Oral Surg Oral Med Oral Pathol
1988;65(1):76–80.
53. Hedemark A, Bang G, Gammeltvedt AT, Anda S. Dental and jaw changes in
primary hyperoxaluria. J Oral Pathol Med Off Publ Int Assoc Oral Pathol
Am Acad Oral Pathol 1989;18(10):586–589.
54. Moskow BS. Periodontal manifestations of hyperoxaluria and oxalosis. J
Periodontol 1989;60(5):271–278.
55. Mehendale HM. Toxicodynamics of low level toxicant interactions of
biological significance: inhibition of tissue repair. Toxicology 1995;105(2–
3):251–266.
56. Khan SR. Reactive oxygen species, inflammation and calcium oxalate
nephrolithiasis. Transl Androl Urol 2014;3(3):256–276.
57. Hoover AA, Karunairatnam NC. Oxalate content of some leafy green
vegetables and its relation to oxaluria and calcium utilization. Biochem J
1945;39(3):237.
58. Castellaro AM, Tonda A, Cejas HH, et al. Oxalate induces breast cancer.
BMC Cancer 2015;15:761.

59. Moorhead PJ, Cooper DJ, Timperley WR. Progressive peripheral neuropathy
in patient with primary hyperoxaluria. Br Med J 1975;2(5966):312–313.
60. Samarneh MM, Shtaynberg N, Goldman M, Epstein E, Kleiner M, ElSayegh S. Severe oxalosis with systemic manifestations. J Clin Med Res
2012;4(1):56–60.
61. Blyth AW (and B Meredith, Blyth MW. Poisons : Their Effects and
Detection. 4th ed. London, England: Charles Griffin and Company; 1906.
62. Tsai M-H, Chang W-N, Lui C-C, et al. Status epilepticus induced by star
fruit intoxication in patients with chronic renal disease. Seizure – Eur J
Epilepsy 2005;14(7):521–525.
63. Auxiliadora-Martins M, Alkmin Teixeira GC, Silva GS da, et al. Severe
encephalopathy after ingestion of star fruit juice in a patient with chronic
renal failure admitted to the intensive care unit. Heart Lung J Crit Care
2010;39(5):448–452.
64. Sun X-Y, Ouyang J-M, Zhu W-Y, Li Y-B, Gan Q-Z. Size-dependent toxicity
and interactions of calcium oxalate dihydrate crystals on Vero renal
epithelial cells. J Mater Chem B 2015;3(9):1864–1878.
65. Mulay SR, Desai J, Kumar SV, et al. Cytotoxicity of crystals involves
RIPK3-MLKL-mediated necroptosis. Nat Commun 2016;7:10274.
66. Elferink JG. The mechanism of calcium oxalate crystal-induced haemolysis
of human erythrocytes. Br J Exp Pathol 1987;68(4):551–557.
67. Lewis LD, Smith BW, Mamourian AC. Delayed sequelae after acute
overdoses or poisonings: cranial neuropathy related to ethylene glycol
ingestion. Clin Pharmacol Ther 1997;61(6):692–699.
68. Chen C-L, Chou K-J, Wang J-S, Yeh J-H, Fang H-C, Chung H-M.
Neurotoxic effects of carambola in rats: the role of oxalate. J Formos Med
Assoc Taiwan Yi Zhi 2002;101(5):337–341.
69. Rahman SS, Kadakia S, Balsam L, Rubinstein S. Autonomic dysfunction as
a delayed sequelae of acute ethylene glycol ingestion : a case report and
review of the literature. J Med Toxicol Off J Am Coll Med Toxicol
2012;8(2):124–129.
70. Adams ND, Carrera GF, Johnson RP, Latorraca R, Lemann J. Calciumoxalate-crystal-induced bone disease. Am J Kidney Dis Off J Natl Kidney
Found 1982;1(5):294–299.
71. Coral A, Holsbeeck M van, Hegg C. Case report 599: Secondary oxalosis
complicating chronic renal failure (oxalate gout). Skeletal Radiol
1990;19(2):147–149.
72. Marconi V, Mofid MZ, McCall C, Eckman I, Nousari HC. Primary
hyperoxaluria: report of a patient with livedo reticularis and digital infarcts.
J Am Acad Dermatol 2002;46(2 Suppl Case Reports):S16-18.
73. Brady HR, Fay WP, Meema HE, Rabinovich S, Rapoport A, Oreopoulos
DG. Oxalate bone disease–an emerging form of renal osteodystrophy. Int J
Artif Organs 1989;12(11):715–719.
74. Symmans PJ, Brady K, Keen CE. Calcium oxalate crystal deposition in
epithelioid histiocytes of granulomatous lymphadenitis: analysis by light and
electronmicroscopy. Histopathology 1995;27(5):423–429.
75. Reginato AJ. Calcium Oxalate and Other Crystals or Particles Associated
with Arthritis. In: Koopman WJ, editor. Arthritis and Allied Conditions.
Philadelphia, PA [etc.]: Lippincott Williams & Wilkins; 2001.
76. Rubenstein MC, Martinelli PT, Bayer-Garner IB, Klebuc MJ, Curry JL, Hsu
S. Persistent cutaneous manifestations of hyperoxaluria after combined
hepatorenal transplantation. Dermatol Online J 2004;10(1).
77. Ermer T, Eckardt KU, Aronson PS, Knauf F. Oxalate, inflammasome, and
progression of kidney disease. Curr Opin Nephrol Hypertens
2016;25(4):363–71.
78. Mulay SR, Kulkarni OP, Rupanagudi KV, et al. Calcium oxalate crystals
induce renal inflammation by NLRP3-mediated IL-1β secretion. J Clin
Invest 2013;123(1):236–246.
79. Speijers GJ. Toxicological data needed for safety evaluation and regulation
on inherent plant toxins. Nat Toxins 1995;3(4):222–226; discussion 242.
80. Singh PP, Kothari LK, Sharma DC, Saxena SN. Nutritional value of foods in
relation to their oxalic acid content. Am J Clin Nutr 1972;25(11):1147–1152.
81. The Low Oxalate Diet Addendum Fall 2008- Numerical Values Table. VP
Found Newsl 2008;(31):7–11.
82. The Low Oxalate Diet Addendum Fall 2012 – Numerical Values Table. VP
Found Newsl 2013;(38).
83. Tang M, Larson-Meyer DE, Liebman M. Effect of cinnamon and turmeric
on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy
subjects. Am J Clin Nutr 2008;87(5):1262–1267.
84. Holmes RP, Kennedy M. Estimation of the oxalate content of foods and
daily oxalate intake. Kidney Int 2000;57(4):1662–1667.
85. Siener R, Ebert D, Nicolay C, Hesse A. Dietary risk factors for
hyperoxaluria in calcium oxalate stone formers. Kidney Int
2003;63(3):1037–1043.
86. Holmes RP, Knight J, Assimos DG. Origin of Urinary Oxalate. American
Institute of Physics; 2007. p. 176–182.
87. Zimmermann DJ, Hesse A, Unruh GE von. Influence of a high-oxalate diet
on intestinal oxalate absorption. World J Urol 2005;23(5):324–329.
88. Holmes RP, Knight J, Assimos DG. Lowering urinary oxalate excretion to
decrease calcium oxalate stone disease. Urolithiasis 2016;44(1):27–32.
89. Yount J, Gottlieb A. The low oxalate cookbook, book two. Graham, NC:
Vulvar Pain Foundation; 2005.
90. The Low Oxalate Diet Addendum Aug. 2004- Numerical Values Table. VP
Found Newsl 2004;(24):9.
91. The Low Oxalate Diet Addendum Summer 2010 – Numerical Values Table.
VP Found Newsl 2010;(34).
92. The Low Oxalate Diet Addendum Winter 2010 – Numerical Values Table.
VP Found Newsl 2010;(33):18–23.
93. The Low Oxalate Diet Addendum Spring 2011 – Numerical Values Table.
VP Found Newsl 2011;(35):14–17.
94. The Low Oxalate Diet Addendum Summer 2012 – Numerical Values Table.
VP Found Newsl 2012;(37):6–9, 19–25.
95. The Low Oxalate Diet Addendum Fall 2014 – Numerical Values Table. VP
Found Newsl 2014;(41):16–17.
96. The Low Oxalate Diet Addendum Spring 2014 – Numerical Values Table.
VP Found Newsl 2014;(40):18–20.
97. The Low Oxalate Diet Addendum Fall 2011 – Numerical Values Table. VP
Found Newsl 2011;(36):17–20.
98. The Low Oxalate Diet Addendum Fall 2007- Numerical Values Table. VP
Found Newsl 2007;(29):8–10.
99. The Low Oxalate Diet Addendum Fall 2013 – Numerical Values Table. VP
Found Newsl 2013;(39):16–17.
100. The Low Oxalate Diet Addendum Spring 2008- Numerical Values Table. VP
Found Newsl 2008;(30):19–22.
101. Hönow R, Hesse A. Comparison of extraction methods for the determination
of soluble and total oxalate in foods by HPLC-enzyme-reactor. Food Chem
2002;78(4):511–521.
102. Autism Oxalate Project Food Testing Results, (University of Wyoming).
Trying Low Oxalates. 2011;
103. The Low Oxalate Diet Addendum Summer 2009 – Numerical Values Table.
VP Found Newsl 2009;(32):8–11.
104. Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW. Oxalobacter
sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion.
Kidney Int 2006;69(4):691–698.
105. Kelly JP, Curhan GC, Cave DR, Anderson TE, Kaufman DW. Factors
related to colonization with Oxalobacter formigenes in U.S. adults. J
Endourol 2011;25(4):673–679.
106. Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the
mouse gut microbiota promoting colitis and metabolic syndrome. Nature
[Internet] 2015 [cited 2015 Mar 2];Available from:
http://www.nature.com/doifinder/10.1038/nature14232
107. Suryavanshi MV, Bhute SS, Jadhav SD, Bhatia MS, Gune RP, Shouche YS.
Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate
metabolizing bacterial species in recurrent kidney stone endures. Sci Rep
2016;6:34712.
108. Sidhu H, Schmidt ME, Cornelius JG, et al. Direct correlation between
hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal
tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut
recolonization or enzyme replacement therapy. J Am Soc Nephrol JASN
1999;10 Suppl 14:S334-40.
109. Dobbins JW. Oxalate and intestinal disease. J Clin Gastroenterol
1979;1(2):165–169.
110. Canos HJ, Hogg GA, Jeffery JR. Oxalate nephropathy due to gastrointestinal
disorders. Can Med Assoc J 1981;124(6):729–733.
111. Gkentzis A, Kimuli M, Cartledge J, Traxer O, Biyani CS. Urolithiasis in
inflammatory bowel disease and bariatric surgery. World J Nephrol
2016;5(6):538–546.
112. Lieske JC, Mehta RA, Milliner DS, Rule AD, Bergstralh EJ, Sarr MG.
Kidney stones are common after bariatric surgery. Kidney Int 2014;
113. Earnest DL, Johnson G, Williams HE, Admirand WH. Hyperoxaluria in
Patients with Ileal Resection: An Abnormality in Dietary Oxalate
Absorption. Gastroenterology 1974;66(6):1114–1122.
114. Humayun Y, Ball KC, Lewin JR, Lerant AA, Fülöp T. Acute oxalate
nephropathy associated with orlistat. J Nephropathol 2016;5(2):79–83.
115. Choudhury D, Ahmed Z. Drug-associated renal dysfunction and injury. Nat
Clin Pract Nephrol 2006;2(2):80–91.
116. Cheungpasitporn W, Thongprayoon C, O’Corragain OA, Edmonds PJ,
Kittanamongkolchai W, Erickson SB. Associations of sugar-sweetened and
artificially sweetened soda with chronic kidney disease: a systematic review
and meta-analysis. Nephrol Carlton Vic 2014;19(12):791–797.
117. Bray GA, Popkin BM. Dietary Sugar and Body Weight: Have We Reached a
Crisis in the Epidemic of Obesity and Diabetes? Health Be Damned! Pour on
the Sugar. Diabetes Care 2014;37(4):950–956.
118. Cirillo P, Gersch MS, Mu W, et al. Ketohexokinase-dependent metabolism
of fructose induces proinflammatory mediators in proximal tubular cells. J
Am Soc Nephrol JASN 2009;20(3):545–553.
119. Johnson RJ, Sanchez-Lozada LG, Nakagawa T. The Effect of Fructose on
Renal Biology and Disease. J Am Soc Nephrol 2010;21(12):2036–2039.
120. Gersch MS, Mu W, Cirillo P, et al. Fructose, but not dextrose, accelerates
the progression of chronic kidney disease. Am J Physiol-Ren Physiol
2007;293(4):F1256–F1261.
121. 2015–2020 Dietary Guidelines for Americans [Internet]. 8th ed. U.S.
Department of Health and Human Services and U.S. Department of
Agriculture.; 2015 [cited 2017 Dec 30]. Available from:
https://health.gov/dietaryguidelines/2015/guidelines/
122. McNally MA, Pyzik PL, Rubenstein JE, Hamdy RF, Kossoff EH. Empiric
use of potassium citrate reduces kidney-stone incidence with the ketogenic
diet. Pediatrics 2009;124(2):e300-304.
123. Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN. Dietary
Protein and Potassium, Diet–Dependent Net Acid Load, and Risk of Incident
Kidney Stones. Clin J Am Soc Nephrol 2016;11(10):1834–1844.
124. Hoppe B, Leumann E, Unruh G von, Laube N, Hesse A. Diagnostic and
therapeutic approaches in patients with secondary hyperoxaluria. Front
Biosci J Virtual Libr 2003;8:e437-443.
125. De Cosmo S, Menzaghi C, Prudente S, Trischitta V. Role of insulin
resistance in kidney dysfunction: insights into the mechanism and
epidemiological evidence. Nephrol Dial Transplant Off Publ Eur Dial
Transpl Assoc – Eur Ren Assoc 2013;28(1):29–36.
126. Thamilselvan V, Menon M, Thamilselvan S. Oxalate at physiological urine
concentrations induces oxidative injury in renal epithelial cells: effect of αtocopherol and ascorbic acid. BJU Int 2014;114(1):140–150.
127. Vervaet BA, Verhulst A, D’Haese PC, Broe MED. Nephrocalcinosis: new
insights into mechanisms and consequences. Nephrol Dial Transplant
2009;24(7):2030–2035.
128. Mulay SR, Evan A, Anders H-J. Molecular mechanisms of crystal-related
kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. Nephrol Dial Transplant
Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc 2014;29(3):507–514.
129. Gambaro G, Valente ML, Zanetti E, et al. Mild tubular damage induces
calcium oxalate crystalluria in a model of subtle hyperoxaluria: Evidence
that a second hit is necessary for renal lithogenesis. J Am Soc Nephrol JASN
2006;17(8):2213–2219.
130. Balcke P, Zazgornik J, Sunder-Plassmann G, et al. Transient hyperoxaluria
after ingestion of chocolate as a high risk factor for calcium oxalate calculi.
Nephron 1989;51(1):32–34.
131. Vermeulen C, Lyon E, Ellis J, Borden T. The renal papilla and
calculogenesis. J Urol 1967;97:573–582.
132. Park J-A, Lee YJ, Lee JW, et al. Evaluation of [(89)Zr]-Oxalate as a PET
Tracer in Inflammation, Tumor, and Rheumatoid Arthritis Models. Mol
Pharm 2016;13(7):2571–2577.
133. Garner A. Retinal oxalosis. Br J Ophthalmol 1974;58(6):613–619.
134. Lieske JC, Norris R, Swift H, Toback FG. Adhesion, internalization and
metabolism of calcium oxalate monohydrate crystals by renal epithelial
cells. Kidney Int 1997;52(5):1291–1301.
135. Doyle WF, Brahman HD, Burgess JH. The nature of yellow-brown bodies in
peritoneal lymph nodes. Arch Pathol 1973;96(5):320–326.
136. Susan Costen Owens. Celiac and the Inflammasome: Reasons for the
Relevance of Oxalate and other Triggers. J Gluten Sensit Summer 2016 Issue
[Internet] 2016;15(3). Available from:
http://www.celiac.com/articles/24438/1/Celiac-and-the-InflammasomeReasons-for-the-Relevance-of-Oxalate-and-other-Triggers /Page1.html
137. Darisipudi MN, Knauf F. An update on the role of the inflammasomes in the
pathogenesis of kidney diseases. Pediatr Nephrol Berl Ger 2016;31(4):535–
544.
138. Knight RQ, Taddonio RF, Smith FB, Weseley S, Pecker HM. Oxalosis:
cause of degenerative spinal stenosis. A case report and review of the
literature. Orthopedics 1988;11(6):955–958.
139. Nakazawa R, Hamaguchi K, Hosaka E, Shishido H, Yokoyama T.
Cutaneous oxalate deposition in a hemodialysis patient. Am J Kidney Dis Off
J Natl Kidney Found 1995;25(3):492–497.
140. Grolleau F, Gamelin L, Boisdron-Celle M, Lapied B, Pelhate M, Gamelin E.
A possible explanation for a neurotoxic effect of the anticancer agent
oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol
2001;85(5):2293–2297.
141. Robertson WG, Hughes H. Importance of mild hyperoxaluria in the
pathogenesis of urolithiasis–new evidence from studies in the Arabian
peninsula. Scanning Microsc 1993;7(1):391-401; discussion 401-402.
142. Park H, Eom M, Won Yang J, Geun Han B, Ok Choi S, Kim JS. Peanutinduced acute oxalate nephropathy with acute kidney injury. Kidney Res
Clin Pract 2014;33(2):109–111.
143. Sasaki M, Murakami M, Matsuo K, et al. Oxalate nephropathy with a
granulomatous lesion due to excessive intake of peanuts. Clin Exp Nephrol
2008;12(4):305–308.
144. Makkapati S, D’Agati VD, Balsam L. “Green Smoothie Cleanse” Causing
Acute Oxalate Nephropathy. Am J Kidney Dis 2018;71(2):281–286.
145. Syed F, Mena-Gutierrez A, Ghaffar U. A Case of Iced-Tea Nephropathy. N
Engl J Med 2015;372(14):1377–8.
146. Sun Y, Horowitz BL, Servilla KS, et al. Chronic Nephropathy from Dietary
Hyperoxaluria: Sustained Improvement of Renal Function after Dietary
Intervention. Cureus 2017;9(3):e1105.
147. Bernardino M, Parmar MS. Oxalate nephropathy from cashew nut intake.
CMAJ Can Med Assoc J J Assoc Medicale Can 2016;
148. Khneizer G, Al-Taee A, Mallick MS, Bastani B. Chronic dietary oxalate
nephropathy after intensive dietary weight loss regimen. J Nephropathol
2017;6(3):126–129.
149. Begbie J. On stomach and nervous disorder, as connected with the oxalic
diathesis. Mon J Med Sci 1849;9:943.
150. Bird G. Urinary Deposits: Their Diagnosis, Pathology and Therapeutical
Indications [Internet]. Fifth. London, England: John Churchill, New
151. Lieske JC, Tremaine WJ, De Simone C, et al. Diet, but not oral probiotics,
effectively reduces urinary oxalate excretion and calcium-oxalate
supersaturation. Kidney Int 2010;78(11):1178–1185.
152. Schwen ZR, Riley JM, Shilo Y, Averch TD. Dietary management of
idiopathic hyperoxaluria and the influence of patient characteristics and
compliance. Urology 2013;82(6):1220–1225.
153. Yendt ER, Cohanim M, Peters L. Reduction of urinary oxalate in primary
hyperoxaluria by diet. Urolithiasis Clin Basic Res 1981;373–377.
154. Yendt ER, Cohanim M, Peters L. Reduction of urinary oxalate excretion in
primary hyperoxaluria by diet. Trans Am Clin Climatol Assoc 1980;91:191–
201.
155. Susan Costen Owens. Trying Low Oxalates, The Autism Oxalate Project
[Internet]. Trying Low Oxalates. 2013;Available from:
http://www.lowoxalate.info/
156. Cohen, H, Reid, JB. Tenosynovitis crepitans associated with oxaluria. Liverp
Medico-Chir J 1935;43:193–9.
157. Bergstralh EJ, Monico CG, Lieske JC, et al. Transplantation Outcomes in
Primary Hyperoxaluria. Am J Transplant Off J Am Soc Transplant Am Soc
Transpl Surg 2010;10(11):2493–2501.
158. Ruder H, Otto G, Schutgens RB, et al. Excessive urinary oxalate excretion
after combined renal and hepatic transplantation for correction of
hyperoxaluria type 1. Eur J Pediatr 1990;150(1):56–58.
159. Tan IL, Zonderland HM, Boevé ER. Oxalosis provoked by extracorporeal
shock wave lithotripsy. Lancet Lond Engl 1994;344(8924):757–758.
160. Blackmon JA, Jeffy BG, Malone JC, Knable AL. Oxalosis involving the
skin: case report and literature review. Arch Dermatol 2011;147(11):1302–
1305.
161. Haqqani MT. Crystals in brain and meninges in primary hyperoxaluria and
oxalosis. J Clin Pathol 1977;30(1):16–18.
162. Ellis SR, Hulton SA, McKiernan PJ, Ville de Goyet J de, Kelly DA.
Combined liver-kidney transplantation for primary hyperoxaluria type 1 in
young children. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc –
Eur Ren Assoc 2001;16(2):348–354.
163. Lefaucheur C, Hill GS, Amrein C, et al. Acute Oxalate Nephropathy: A New
Etiology for Acute Renal Failure Following Nonrenal Solid Organ
Transplantation. Am J Transplant 2006;6(10):2516–2521.
164. Pennington JAT, Spungen J. Bowes & Church’s food values of portions
commonly used. Philadelphia, PA: Lippincott, Williams & Wilkins; 2010.
165. Genuis SJ, Kelln KL. Toxicant exposure and bioaccumulation: a common
and potentially reversible cause of cognitive dysfunction and dementia.
Behav Neurol 2015;2015:620143.
166. Norton S. When Healthy Isn’t: The Risks of High Oxalate Foods. Well J
2015;24(4).

מומלצי החודש

מתעניינים? השאירו פרטים. נחזור מהר!